If you liked this article you might like

Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
Neurocrine Drug Fails to Reduce Tic Severity in Tourette Syndrome Patients
Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears
Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference